{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:19:13Z","timestamp":1770715153002,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00769-6","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:40:03Z","timestamp":1761900003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0739-9654","authenticated-orcid":false,"given":"Elaheh","family":"Abiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmeh","family":"Hemmatian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"769_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.01.003","author":"S Gimenez","year":"2025","unstructured":"Gimenez S, et al. Monocytic reactive oxygen species\u2013induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine. J Allergy Clin Immunol. 2025. https:\/\/doi.org\/10.1016\/j.jaci.2025.01.003.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"769_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.advms.2024.03.006","volume":"69","author":"M Kahrizi","year":"2024","unstructured":"Kahrizi M, Saeed, et al. Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis. Adv Med Sci. 2024;69(1):190\u20137.","journal-title":"Adv Med Sci"},{"key":"769_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1335352","volume":"14","author":"R Cezar","year":"2024","unstructured":"Cezar R, et al. T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID. Front Immunol. 2024;14:1335352.","journal-title":"Front Immunol"},{"key":"769_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568439","volume":"16","author":"J Wro\u0144ski","year":"2025","unstructured":"Wro\u0144ski J, et al. Beyond interferon gamma-decreased cellular response to COVID-19 vaccination booster in patients with autoimmune inflammatory rheumatic diseases. Front Immunol. 2025;16:1568439.","journal-title":"Front Immunol"},{"issue":"10","key":"769_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4049\/jimmunol.2300783","volume":"212","author":"S Saito","year":"2024","unstructured":"Saito S, et al. The role of coinhibitory receptors in B cell dysregulation in SARS-CoV-2\u2013infected individuals with severe disease. J Immunol. 2024;212(10):1540\u201352.","journal-title":"J Immunol"},{"issue":"7","key":"769_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2024.104021","volume":"31","author":"FQB Alenzi","year":"2024","unstructured":"Alenzi FQB. Survivin: a key apoptosis inhibitor in COVID-19 infection and its implication for treatment protocol. Saudi J Biol Sci. 2024;31(7):104021.","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"769_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56334-5","volume":"14","author":"Z Nasiri","year":"2024","unstructured":"Nasiri Z, et al. The impact understanding of exosome therapy in COVID-19 and preparations for the future approaches in dealing with infectious diseases and inflammation. Sci Rep. 2024;14(1):5724.","journal-title":"Sci Rep"},{"issue":"12","key":"769_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14326","volume":"23","author":"RJ Valderr\u00e1bano","year":"2024","unstructured":"Valderr\u00e1bano RJ, et al. Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID-19. Aging Cell. 2024;23(12):e14326.","journal-title":"Aging Cell"},{"issue":"1","key":"769_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02408-9","volume":"21","author":"R Heydari","year":"2024","unstructured":"Heydari R, et al. Long non-coding RNAs in biomarking COVID-19: a machine learning-based approach. Virol J. 2024;21(1):134.","journal-title":"Virol J"},{"issue":"2","key":"769_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1861","volume":"7","author":"K Khanaliha","year":"2024","unstructured":"Khanaliha K, et al. Analyzing the expression pattern of the noncoding RNAs (HOTAIR, PVT-1, XIST, H19, and miRNA\u201034a) in PBMC samples of patients with COVID\u201019, according to the disease severity in Iran during 2022\u20132023: a cross\u2010sectional study. Health Sci Rep. 2024;7(2):e1861.","journal-title":"Health Sci Rep"},{"key":"769_CR11","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402598","volume":"7","author":"E-S Lee","year":"2024","unstructured":"Lee E-S, et al. Inflammatory risk contributes to post-COVID endothelial dysfunction through anti-ACKR1 autoantibody. Life Sci Alliance. 2024;7:7.","journal-title":"Life Sci Alliance"},{"issue":"6","key":"769_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063280","volume":"25","author":"\u0141ukasz Huminiecki","year":"2024","unstructured":"Huminiecki \u0141ukasz. Bulk and single-cell RNA sequencing elucidate the etiology of severe COVID-19. Int J Mol Sci. 2024;25(6):3280.","journal-title":"Int J Mol Sci"},{"key":"769_CR13","doi-asserted-by":"crossref","unstructured":"Ghosh S, Chatterjee A, Maitra A. An insight into COVID-19 host immunity at single-cell resolution. Int Rev Immunol. 2024;43:1\u201316.","DOI":"10.1080\/08830185.2024.2443420"},{"issue":"1","key":"769_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41467-023-44524-0","volume":"15","author":"QX Lin","year":"2024","unstructured":"Lin QX, Xuan, et al. Longitudinal single cell atlas identifies complex Temporal relationship between type I interferon response and COVID-19 severity. Nat Commun. 2024;15(1):567.","journal-title":"Nat Commun"},{"key":"769_CR15","doi-asserted-by":"crossref","unstructured":"Spri\u0146\u0123e ML, et al. Unveiling the immune landscape of COVID-19 and prolonged Long-COVID through Single-Cell RNA Sequencing. BioRxiv. 2025:2025\u201303.","DOI":"10.1101\/2025.03.05.641671"},{"issue":"1","key":"769_CR16","doi-asserted-by":"publisher","first-page":"24235","DOI":"10.1038\/s41598-024-75776-5","volume":"14","author":"EC Bispo","year":"2024","unstructured":"Bispo EC, Iseke, et al. Immunomodulatory effect of IFN-\u03b3 licensed adipose-mesenchymal stromal cells in an in vitro model of inflammation generated by SARS-CoV-2 antigens. Sci Rep. 2024;14(1):24235.","journal-title":"Sci Rep"},{"issue":"7","key":"769_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/08820139.2024.2385992","volume":"53","author":"P\u0131nar Cetinkaya","year":"2024","unstructured":"Cetinkaya P\u0131nar, Gur, et al. Plasma extracellular vesicles derived from pediatric COVID-19 patients modulate monocyte and T cell immune responses based on disease severity. Immunol Investig. 2024;53(7):1141\u201375.","journal-title":"Immunol Investig"},{"key":"769_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.10.004","author":"Valentino D\u2019Onofrio","year":"2024","unstructured":"D\u2019Onofrio Valentino, S\u00e9kaly Rafick Pierre. The immune\u2013endocrine interplay in sex differential responses to viral infection and COVID-19. Trends Immunol. 2024. https:\/\/doi.org\/10.1016\/j.it.2024.10.004.","journal-title":"Trends Immunol"},{"key":"769_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1517933","volume":"16","author":"N \u0106wilichowska-Pu\u015blecka","year":"2025","unstructured":"\u0106wilichowska-Pu\u015blecka N, et al. Understanding the long-term interplay of SARS-CoV-2 immune and inflammatory responses with proteases in COVID-19 recovery: a longitudinal study. Front Immunol. 2025;16:1517933.","journal-title":"Front Immunol"},{"issue":"4","key":"769_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/v16040497","volume":"16","author":"C Barbati","year":"2024","unstructured":"Barbati C, et al. The glycan ectodomain of SARS-CoV-2 spike protein modulates cytokine production and expression of CD206 mannose receptor in PBMC cultures of pre-COVID-19 healthy subjects. Viruses. 2024;16(4):497.","journal-title":"Viruses"},{"issue":"1","key":"769_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09464-0","volume":"24","author":"D Zhou","year":"2024","unstructured":"Zhou D, et al. Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance. BMC Infect Dis. 2024;24(1):567.","journal-title":"BMC Infect Dis"},{"key":"769_CR22","doi-asserted-by":"crossref","unstructured":"Gavriilidis GI, et al. APNet, an explainable sparse deep learning model to discover differentially active drivers of severe COVID-19. Bioinformatics. 2025:btaf063.","DOI":"10.1093\/bioinformatics\/btaf063"},{"key":"769_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1358725","volume":"15","author":"R Jia","year":"2024","unstructured":"Jia R, et al. Immunological characterization and comparison of children with COVID-19 from their adult counterparts at single-cell resolution. Front Immunol. 2024;15:1358725.","journal-title":"Front Immunol"},{"key":"769_CR24","doi-asserted-by":"crossref","unstructured":"Jana S. Role of apoptosis in viral infections with special reference to COVID-19: therapeutic targets and Strategies. In: apoptosis and human health: Understanding mechanistic and therapeutic potential. Singapore: Springer Nature Singapore; 2024. p. 325\u201339.","DOI":"10.1007\/978-981-97-7905-5_15"},{"issue":"23","key":"769_CR25","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1111\/bph.17322","volume":"181","author":"Pedro RJ Almeida","year":"2024","unstructured":"Almeida Pedro RJ, et al. Effects of a pro-resolving drug in COVID\u201019: preclinical studies to a randomized, placebo\u2010controlled, phase Ib\/IIa trial in hospitalized patients. Br J Pharmacol. 2024;181(23):4750\u201365.","journal-title":"Br J Pharmacol"},{"key":"769_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/app142311048","volume":"14","author":"S Hall","year":"2024","unstructured":"Hall S, Berger G, Lehmann C. COVID-19 lung injury: unique and familiar aspects of pathophysiology. Appl Sci. 2024;14:11048.","journal-title":"Appl Sci"},{"issue":"2","key":"769_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biology8020026","volume":"8","author":"PJ McGuire","year":"2019","unstructured":"McGuire PJ. Mitochondrial dysfunction and the aging immune system. Biology. 2019;8(2):26.","journal-title":"Biology"},{"issue":"3","key":"769_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/life11030232","volume":"11","author":"S Elesela","year":"2021","unstructured":"Elesela S, Nicholas W. Lukacs. Role of mitochondria in viral infections. Life. 2021;11(3):232.","journal-title":"Life"},{"issue":"12","key":"769_CR29","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/bph.16062","volume":"180","author":"E Mishra","year":"2023","unstructured":"Mishra E. Mitophagy: a promising therapeutic target for neuroprotection during ageing and age-related diseases. Br J Pharmacol. 2023;180(12):1542\u201361.","journal-title":"Br J Pharmacol"},{"key":"769_CR30","doi-asserted-by":"crossref","unstructured":"Lee Y, Haeng et al. Targeting mitochondrial oxidative stress as a strategy to treat aging and age-related diseases. Antioxidants 12.4 (2023):934.","DOI":"10.3390\/antiox12040934"},{"issue":"11","key":"769_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/life13112121","volume":"13","author":"A Mohan","year":"2023","unstructured":"Mohan A, et al. Navigating the post-COVID-19 immunological era: understanding long COVID-19 and immune response. Life. 2023;13(11):2121.","journal-title":"Life"},{"issue":"1","key":"769_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00426-x","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang T, et al. Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era. Exp Hematol Oncol. 2023;12(1):66.","journal-title":"Exp Hematol Oncol"},{"key":"769_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954985","volume":"13","author":"B Tappe","year":"2022","unstructured":"Tappe B, et al. COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds. Front Immunol. 2022;13:954985.","journal-title":"Front Immunol"},{"key":"769_CR34","doi-asserted-by":"publisher","first-page":"111260","DOI":"10.1016\/j.intimp.2023.111260","volume":"126","author":"E Shevela","year":"2024","unstructured":"Shevela E, Ya, et al. Intranasal immunotherapy with M2 macrophage soluble factors in post-COVID hyposmia: a pilot study. Int Immunopharmacol. 2024;126:111260.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"769_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/life14020246","volume":"14","author":"H-C Chen","year":"2024","unstructured":"Chen H-C, et al. Monoclonal antibodies as a therapeutic strategy against multidrug-resistant bacterial infections in a post-COVID-19 era. Life. 2024;14(2):246.","journal-title":"Life"},{"issue":"5","key":"769_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2217\/imt-2021-0168","volume":"14","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, et al. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. 2022;14(5):351\u201371.","journal-title":"Immunotherapy"},{"key":"769_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini V, et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol. 2023;14:1161067.","journal-title":"Front Immunol"},{"issue":"16","key":"769_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/su12166561","volume":"12","author":"D Lee","year":"2020","unstructured":"Lee D, Kang J, Kim K. Global collaboration research strategies for sustainability in the post COVID-19 era: analyzing virology-related national-funded projects. Sustainability. 2020;12(16):6561.","journal-title":"Sustainability"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00769-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:40:13Z","timestamp":1761900013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00769-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00769-6","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study involving human participants were conducted according to the ethical standards of the institutional and national research committee and of the 1975 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Biomedical Research Ethics Committee of Damghan Islamic Azad University, which issued the study\u2019s code of ethics (IR.IAU. DAMGHAN.REC.1400.005). Before data collection, written informed consent was obtained from all subjects participating in the study. To comply with ethical considerations, all medical record information was kept confidential. The names and surnames of participants were not used for data collection, and data collection was carried out after obtaining the code of ethics from Damghan Islamic Azad University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"86"}}